Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

PGT Inc. (PGTI) is the Top Small-Cap Star for July 29

ARWR, GEVO, PGTI, STML, ZLTQ

Equities.com Small-Cap Stars, our proprietary list of small-cap companies best-positioned for future success, generated returns of 45.32% in 2013. And this year’s list is full of even more small caps potentially poised to make big gains.

Here are today’s top-performing Small-Cap Stars:

Pgt Inc. (PGTI)

Pgt Inc. gained 27.33% to $9.41 a share. The gains came on a volume of 3,432,560 shares against an average daily volume of 515,356 shares. Pgt Inc. has had a trading range from $12.61 to $7.34 over the last year, its P/E ratio is 15.9, it has a 50-day SMA of $8.38, and a 200-day SMA of $9.94.

PGT, Inc. is a U.S. manufacturer and supplier manufacturer of impact-resistant aluminum and vinyl-framed windows and doors and offers a broad range of fully customizable window and door products.

Gevo Inc. (GEVO)

Gevo Inc. gained 12.92% to $0.70 a share. The gains came on a volume of 3,903,170 shares against an average daily volume of 400,559 shares. Gevo Inc. has had a trading range from $2.18 to $0.55 over the last year, it has a 50-day SMA of $0.85, and a 200-day SMA of $1.23.

Gevo Inc is a renewable chemicals and advanced biofuels company focused on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks.

Arrowhead Research Corp (ARWR)

Arrowhead Research Corp gained 11.47% to $11.95 a share. The gains came on a volume of 6,423,680 shares against an average daily volume of 2,063,415 shares. Arrowhead Research Corp has had a trading range from $27.63 to $3.10 over the last year, it has a 50-day SMA of $12.80, and a 200-day SMA of $12.96.

Arrowhead Research Corp is a biopharmaceutical company developing targeted RNAi therapeutics.

Stemline Therapeutics Inc. (STML)

Stemline Therapeutics Inc. gained 10.92% to $12.80 a share. The gains came on a volume of 148,124 shares against an average daily volume of 130,040 shares. Stemline Therapeutics Inc. has had a trading range from $47.25 to $10.68 over the last year, it has a 50-day SMA of $14.00, and a 200-day SMA of $20.52.

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

Zeltiq Aesthetics Inc. (ZLTQ)

Zeltiq Aesthetics Inc. gained 8.64% to $16.59 a share. The gains came on a volume of 664,260 shares against an average daily volume of 455,218 shares. Zeltiq Aesthetics Inc. has had a trading range from $24.79 to $5.87 over the last year, it has a 50-day SMA of $15.88, and a 200-day SMA of $17.05.

ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as CoolSculpting system which is a non-invasive product for the selective reduction of body fat.

Equities.com's Small-Cap Stars: One Way to Make Your Alpha Shine Bright

Equities.com's Small-Cap Stars are a portfolio of small-cap companies that our system has identified as being best situated for future success based on their fundamentals. The list is built by looking at small-cap companies that recently made large gains, identifying which fundamental metrics they had in common prior to their growth, running a statistical regression to isolate those metrics most-predictive of future success, and seeking out those small caps in the current market that best resemble that profile.

Our list of 369 companies represent those that should be in the best position to take advantage of what the market has to offer and have the highest potential to create big returns.

All data provided by QuoteMedia and was accurate as of 4:30 pm ET.

Rate this press release
3 stars
v
Usefulness

Clarity

Credibility
Add to favourites icon Add to favourites